| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a95d62831e0d6991144555092cbc689e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-202 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03 |
| filingDate |
2003-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c017ee195168dc9f7f8b8ccd20033058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cad945e1eb831a88b856836ca7aa68ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_433ffbae791af21af42e4946d3b067c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d947845cd0497b43f60caac857a2fb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd28b8eb2c89d98c77b976d134b4e499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_095ef4cc22d15a6e81265e290954c69a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_199af3c2e9200c02e934a53a5c1f68e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7db17e279ef817cd1b1c6d31cbcd251f |
| publicationDate |
2005-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20050045429-A |
| titleOfInvention |
Pharmaceutical composition comprising the extract of scytosiphon lomentaria for treating or preventing leukemia disease and cancer |
| abstract |
The present invention relates to a pharmaceutical composition for the treatment and prevention of cancer diseases containing crude ring extract and non-polar solvent soluble extract as an active ingredient. The Korimae extract exhibits anticancer efficacy and apoptosis inducing effect of HL-60 leukemia cells, and thus can be used as a medicine and health functional food useful for leukemia or cancer-related diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100826560-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101110063-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105597080-A |
| priorityDate |
2003-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |